Calcific aortic stenosis (AS) is the most prevalent heart valve disorder in developed
countries. It is characterized by progressive fibro-calcific remodelling and thickening of the …

Aims In view of the currently available evidence from randomized trials, we aimed to
compare the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) …

Background Frailty is a geriatric syndrome that diminishes the potential for functional
recovery after a transcatheter aortic valve replacement (TAVR) or surgical aortic valve …

Background: Post-market surveillance is needed to evaluate the real-world clinical
effectiveness and safety of US Food and Drug Administration–approved devices. Objectives …

Importance Transcatheter aortic valve replacement (TAVR) indications are expanding,
leading to an increasing number of patients with bicuspid aortic stenosis undergoing TAVR …

Abstract Background: The Society of Thoracic Surgeons (STS)/American College of
Cardiology Transcatheter Valve Therapy (TVT) Registry captures all procedures with Food …

Background Adoption of the results of large-scale randomized controlled trials in
percutaneous coronary intervention (PCI) may differ internationally, yet few studies have …

Abstract Background The Evolut Low Risk Trial (Medtronic Evolut Transcatheter Aortic Valve
Replacement in Low Risk Patients) showed that transcatheter aortic valve replacement …

Abstract Background: The Society of Thoracic Surgeons (STS)/American College of
Cardiology (ACC) Transcatheter Valve Therapy (TVT) Registry has been a joint initiative of …

In the 16 years since the first pioneering procedure, transcatheter aortic valve implantation
(TAVI) has come of age and become a routine strategy for aortic valve replacement …